NCT02902978View on ClinicalTrials.gov

A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 26, 2016

Primary Completion Date

August 17, 2017

Study Completion Date

August 17, 2017

Conditions
Japanese Healthy Adult Male Participants
Interventions
DRUG

E6130

DRUG

Placebo

E6130 matched placebo

Trial Locations (1)

Unknown

Sumida City

All Listed Sponsors
lead

EA Pharma Co., Ltd.

INDUSTRY

NCT02902978 - A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects | Biotech Hunter | Biotech Hunter